Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Share News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: SIMEC gets payment; Molecular Energies to delist

Thu, 28th Mar 2024 11:00

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

SIMEC Atlantis Energy Ltd, up 27% at 1 pence, 12-month range 0.70p-1.80p. The energy company focused on tidal energy receives its first GBP5 million milestone payment under its agreement with EL (Uskmouth) Ltd, a subsidiary of FPC Electric Land. In December, SAE announced that it had agreed to sell the freehold land owned by SAE to EL, for a milestone-linked total gross cash consideration of GBP9.8m million. The freehold land sold to EL is limited to the land used by Quinbrook Infrastructure Partners, for their 230-megawatt battery energy storage system at SAE's Uskmouth Sustainable Energy Park. With the achievement of this first milestone and the payment of GBP5 million to SAE, EL has now taken ownership of this land. SAE Chief Executive Officer Graham Reid comments: "This is another milestone hit and demonstrates how we secure value for our business and shareholders. We have the knowledge, skills and a fantastic site to deliver an exciting pipeline of projects that are expected to provide revenue for the business and increased value for our shareholders in the long term. This experience and knowledge can also provide a platform for future growth, and it's a truly exciting time at SAE."

----------

AIM - LOSERS

----------

Molecular Energies PLC, down 81% at 4.5p, 12-month range 4.18p-144.16p. The North, Central and South America-focused oil and gas company proposes cancelling its listing on AIM in London, saying it can no longer justify the "disproportionately high costs"."I take no joy in recommending the cancellation of trading in Molecular's shares on AIM and know that this proposal will impact many shareholders. However the primary benefits of being listed are to avail oneself of access to capital, the ability to utilise one's shares as currency and enjoying the reputational boost of being on the London Stock Exchange. Molecular no longer receives any of those benefits," says Chair Peter Levine. "As a group its interests are best served by turning to the private arena where Molecular can regenerate away from the microscope and constraints of the public markets yet avail itself of funding and exit opportunities in some ways more flexible and abundant than remaining as a small public company on the London market."

----------

Byotrol PLC, down 60% at 0.15p, 12-month range 0.098p-2.60p. The manufacturer of biocidal and antimicrobial cleaning products also proposes cancellation of AIM listing and re-registration as private company, as its directors conclude that it is no longer financially viable to continue trading shares publicly. In a trading update, Byotrol says it expects product sales in the financial year ending Sunday to be in line with expectations at GBP3.9 million, up 5.4% from GBP3.7 million a year earlier on a like-for-like basis, excluding discontinued items. It now expects headline loss before interest, tax, depreciation and amortisation, before exceptionals, of GBP1.0 million, widening from GBP700,000 a year earlier.

----------

By Greg Rosenvinge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
27 Apr 2023 17:35

TRADING UPDATES: Yourgene Health sees revenue above market forecasts

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
27 Apr 2023 14:15

Byotrol re-shuffles board after end of financial year

(Sharecast News) - Specialist infection prevention technology company Byotrol said in an update on Thursday that it expected its results for the financial year just ended to be in line with market expectations, subject to audit.

Read more
22 Nov 2022 14:52

Byotrol Chair John Langlands retires; appoints executive chair and CEO

(Alliance News) - Byotrol PLC on Tuesday said it appointed chief executive officer David Traynor as executive chair with immediate effect, as non-executive chair John Langlands will retire from the business.

Read more
30 Aug 2022 14:36

IN BRIEF: Byotrol swings to annual loss on lower sales, overstocking

Byotrol PLC- Manchester, England based firm - Swings to a pretax loss of GBP1.3 million for the year that ended on March 31, from a profit of GBP1.0 million the year before. Revenue plunges to GBP6.3 million from GBP11.2 million, as product sales fall 49% to GBP5.2 million from GBP10.2 million.

Read more
28 Jul 2022 20:08

TRADING UPDATES: Scottish American outperforms; Amte picks Dundee

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
11 Jul 2022 21:40

TRADING UPDATES: Byotrol anticipating positive full-year earnings

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
11 Jul 2022 14:42

Byotrol achieves full-year market expectations

(Sharecast News) - Infection prevention technology developer Byotrol reported full-year sales of £6.3m in a trading update on Monday, consisting of £5.2m from product sales and £1.1m from intellectual property sales and royalties.

Read more
2 Mar 2022 19:27

TRADING UPDATES: Eden Research, Abingdon guide for weaker results

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
8 Dec 2021 14:46

Byotrol revenue and profit fall due to pandemic and Brexit woes

Byotrol revenue and profit fall due to pandemic and Brexit woes

Read more
8 Dec 2021 11:45

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

Read more
3 Nov 2021 14:13

EXECUTIVE CHANGES: MaxCyte promotes to chair; Sanderson adds retailers

EXECUTIVE CHANGES: MaxCyte promotes to chair; Sanderson adds retailers

Read more
2 Nov 2021 15:01

EXECUTIVE CHANGES: CFOs drop like flies; ex-IG CEO to chair Scotgold

EXECUTIVE CHANGES: CFOs drop like flies; ex-IG CEO to chair Scotgold

Read more
2 Nov 2021 09:57

AIM WINNERS & LOSERS: Warpaint sees profit topping market forecasts

AIM WINNERS & LOSERS: Warpaint sees profit topping market forecasts

Read more
13 Oct 2021 16:10

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
1 Oct 2021 10:30

Byotrol sells American rights to antimicrobial formulation

(Sharecast News) - Byotrol said on Friday that it has completed the sale in the Americas of its US Environmental Protection Agency (EPA)-registered, long-lasting antimicrobial surface spray to its existing licensee, Integrated Resources (IRI).

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.